chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: debilitating migraine headache; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 19Mar2021 at 12:45 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included osteoarthritis and rheumatoid arthritis. Patient received unspecified concomitant medication on an unspecified date and for unspecified indication. Any allergies to medications, food, or other products were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021 at 13:15, the patient experienced debilitating migraine headache. Treatment taken for adverse event was reported as unknown. The clinical outcome of debilitating migraine headache was not recovered.   No follow up attempts are possible; Information about lot/batch number has been requested.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Malaise, Vaccination site pain
Clinical narrative: Pain at the injection site; Tiredness; feeling unwell; This is a spontaneous report from contactable consumer, the patient. A 44-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534), via an unspecified route of administration to his left arm on 22Mar2021 at 3:30 PM for COVID-19 immunisation. Medical history and concomitant medications of the patient was not reported. The patient had no allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. On 22Mar2021 at 21:00 PM the patient experienced pain at the injection site which began several hours after injection, leading to intense stabbing pain whenever the upper arm was moved, tiredness and generally feeling unwell. The adverse event did not result in doctor or other healthcare professional office or clinic visit or emergency room visit. The patient did not receive any treatment for the adverse event. The clinical outcome of the event pain at the vaccination site pain, tiredness and feeling unwell was not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Impaired self-care, Tremor
Clinical narrative: tremors have gotten very much worse; To the point of not being able to feed himself; Difficulty with walking (now needs the aid of a walker).; This is a spontaneous report from a contactable consumer (patient). A 69-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EN6208), dose 2 via an unspecified route of administration, administered in right arm on 21Mar2021 13:30 (at the age of 69-years-old) as single dose for COVID-19 immunization. Medical history included Parkinson's with mild to moderate tremors (ongoing) and diabetes. Concomitant medications were not reported. The patient historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6200) dose 1 via an unspecified route of administration, administered in right arm on 28Feb2021 02:00PM (at the age of 69-years-old) as single dose for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed for COVID-19 prior vaccination. On 22Mar2021 at 04:00 PM, within 12 hrs of receiving his 2nd dose of the Pfizer vaccine his tremors have gotten very much worse, to the point of not being able to feed himself and difficulty with walking (now needs the aid of a walker). No treatment was received for the reported events. The patient had not tested for COVID-19 since vaccination. The outcome of the events was reported as not recovered.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dyspnoea, Heart rate increased, Influenza like illness, Rash
Clinical narrative: Rash in both arms, torso, neck and face; hard time breathing; fast heart beat; weaknesses; flu-like symptoms; This is a spontaneous report received from a contactable consumer (patient). A 44-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number and Expiration date: Not reported), dose 1 via an unspecified route of administration in the right arm on 08 Mar2021 at 17:45 as dose 1, single (at the age of 44years) for COVID-19 immunization at pharmacy or drug Store. Patient's medical history included MCAS (Mast cell activation syndrome), POTS syndrome (postural orthostatic tachycardia syndrome), and had known allergy to medications, food, or other products. The patient's concomitant medications included Fludrocortisone (MANUFACTURER UNKNOWN), Metoprolol (MANUFACTURER UNKNOWN), famotidine (PEPCID), and cetirizine hydrochloride (ZYRTEC); all taken for an unspecified indication, start and stop date were not reported. Prior to vaccination, patient was not diagnosed with COVID-19 and not received any other vaccines within 4 weeks. On 12Mar2021 at 10:00, the patient experienced rash in both arms, torso, neck and face, hard time breathing, fast heartbeat, weaknesses, flu-like symptoms. Since the vaccination, the patient has not been tested for COVID-19. Patient visited to doctor or other healthcare professional office/clinic and emergency room/department or urgent care. Patient received treatment with singular, benadryl for reported events. The outcome of the events was not recovering.  Information on the lot/batch number has been requested.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Fatigue, Malaise
Clinical narrative: Tiredness; joint pain; feeling un well; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received an unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route of administration on 16Mar2021 at 1400 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient was allergic to cephalexin and zithromax Z-Pak. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not tested positive for COVID-19. On 16Mar2021 at 2100, the patient experienced tiredness, joint pain and feeling unwell. The patient did not receive any treatment for the events experienced. The clinical outcome of the events tiredness, joint pain and feeling unwell was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia
Clinical narrative: Tiredness; joint pain; feeling un well; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received an unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route of administration on 16Mar2021 at 1400 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient was allergic to cephalexin and zithromax Z-Pak. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not tested positive for COVID-19. On 16Mar2021 at 2100, the patient experienced tiredness, joint pain and feeling unwell. The patient did not receive any treatment for the events experienced. The clinical outcome of the events tiredness, joint pain and feeling unwell was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chills, Dyspepsia, Fatigue, Inappropriate schedule of product administration
Clinical narrative: Inappropriate schedule of vaccine administered; Chest discomfort; Felt like a bad case of indigestion; Fatigue; Low grade fever; Chills; This is a spontaneous report from a contactable consumer, the patient. A 78-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9262), via unspecified route on left arm on 02Mar2021 at 13:15 (at the age of 78-year-old), as a single dose for COVID-19 immunisation. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9262), as a single dose via unspecified route in left arm on 11Mar2021 (at the age of 78-year-old) (inappropriate schedule of vaccine administered) as a single dose for COVID-19 immunisation. Medical history included bronchiectasis, asthma, lymphocytic colitis. The patient had no allergies to medications, food, or other products. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Mar2021 at 19:00 PM, the patient experienced fatigue, low grade fever, chills, felt like a bad case of indigestion and chest discomfort. It was reported that he patient still experienced these events 10 days after second vaccination. No treatment was received for the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fatigue, low grade fever, chills, felt like a bad case of indigestion and chest discomfort was not recovered.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Inappropriate schedule of vaccine administered; Chest discomfort; Felt like a bad case of indigestion; Fatigue; Low grade fever; Chills; This is a spontaneous report from a contactable consumer, the patient. A 78-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9262), via unspecified route on left arm on 02Mar2021 at 13:15 (at the age of 78-year-old), as a single dose for COVID-19 immunisation. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9262), as a single dose via unspecified route in left arm on 11Mar2021 (at the age of 78-year-old) (inappropriate schedule of vaccine administered) as a single dose for COVID-19 immunisation. Medical history included bronchiectasis, asthma, lymphocytic colitis. The patient had no allergies to medications, food, or other products. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Mar2021 at 19:00 PM, the patient experienced fatigue, low grade fever, chills, felt like a bad case of indigestion and chest discomfort. It was reported that he patient still experienced these events 10 days after second vaccination. No treatment was received for the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fatigue, low grade fever, chills, felt like a bad case of indigestion and chest discomfort was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Body temperature, Chills, Fatigue, Headache
Clinical narrative: stomach ache; body aches; Right side of throat pain when swallowing; Extremely swollen lymph nodes in armpit, above & below collar bone on left side; Fever 102-103 for 3 days; chills; headache; nausea; fatigue; Swollen lymph nodes right side of neck; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207), via an unspecified route of administration in the left arm on 16Mar2021 at 12:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergies. The patient was allergic to penicillin and codeine (MANUFACTURER UNKNOWN). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6201), via an unspecified route of administration in the left arm on 23Feb2021 at 12:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 16Mar2021, the patient had fever 102-103 for 3 days, body aches and chills for 4 days. The patient also experienced headache, nausea, stomach ache for 3 days and fatigue for 7 days. The patient had extremely swollen lymph nodes in armpit, above & below collar bone on left side for 7 days and these were still swollen in the above and below collar bone. The patient experienced right side throat pain when swallowing for 3 days which was still painful. The patient had swollen lymph nodes on right side of neck for 3 days which were still swollen. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events fever, headache, nausea, stomach ache, body aches, chills, fatigue, swollen lymph nodes, axillary lymph nodes enlarged and throat pain. The clinical outcomes of the events fever, headache, nausea, stomach ache, body aches, chills, fatigue, swollen lymph nodes, axillary lymph nodes enlarged and throat pain was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Nausea, Oropharyngeal pain, Pain, Pyrexia
Clinical narrative: stomach ache; body aches; Right side of throat pain when swallowing; Extremely swollen lymph nodes in armpit, above & below collar bone on left side; Fever 102-103 for 3 days; chills; headache; nausea; fatigue; Swollen lymph nodes right side of neck; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207), via an unspecified route of administration in the left arm on 16Mar2021 at 12:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergies. The patient was allergic to penicillin and codeine (MANUFACTURER UNKNOWN). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6201), via an unspecified route of administration in the left arm on 23Feb2021 at 12:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 16Mar2021, the patient had fever 102-103 for 3 days, body aches and chills for 4 days. The patient also experienced headache, nausea, stomach ache for 3 days and fatigue for 7 days. The patient had extremely swollen lymph nodes in armpit, above & below collar bone on left side for 7 days and these were still swollen in the above and below collar bone. The patient experienced right side throat pain when swallowing for 3 days which was still painful. The patient had swollen lymph nodes on right side of neck for 3 days which were still swollen. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events fever, headache, nausea, stomach ache, body aches, chills, fatigue, swollen lymph nodes, axillary lymph nodes enlarged and throat pain. The clinical outcomes of the events fever, headache, nausea, stomach ache, body aches, chills, fatigue, swollen lymph nodes, axillary lymph nodes enlarged and throat pain was unknown.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm after receiving first dose; This is a spontaneous report from a non-contactable consumer. A female patient of an unspecified age received her first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced sore arm after receiving first dose. The clinical outcome of the sore arm was unknown.  No follow-up attempts are possible; information about lot number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Headache, Pyrexia
Clinical narrative: Fever 100; Aches /joints hurt; Headache; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8739), via an unspecified route of administration in right arm on 22March2021 at 19:15 as a single dose for COVID-19 immunisation. Medical history was not provided. Concomitant medication was not provided. The patient was diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to vaccination. On 23March2021, at 19:45 the patient experienced fever 100 (unit and reference range was not provided), joint ache, and headache. The patient did not receive any treatment for the adverse event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of fever100, joint ache and headache was not recovered. No follow up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Vaccination site pain, Vaccination site warmth
Clinical narrative: On March 23rd (12 days afterinjection), in the morning, I noticedthat the injection site was red, hot tothe touch, and slightly painful withapplied pressure. I noticed it again inthe evening when it became slightlyitchy.; On March 23rd (12 days afterinjection), in the morning, I noticedthat the injection site was red, hot tothe touch, and slightly painful withapplied pressure. I noticed it again inthe evening when it became slightlyitchy.; On March 23rd (12 days afterinjection), in the morning, I noticedthat the injection site was red, hot tothe touch, and slightly painful withapplied pressure. I noticed it again inthe evening when it became slightlyitchy.; On March 23rd (12 days afterinjection), in the morning, I noticedthat the injection site was red, hot tothe touch, and slightly painful withapplied pressure. I noticed it again inthe evening when it became slightlyitchy.; This is a spontaneous report from a contactable consumer, the patient. This report received from a 51-year-old non-pregnant female patient received the first dose of BNT162B2 (Pfizer BioNTech Covid 19 mRNA Vaccine; lot number: EN6199) via unspecified route of administration in left arm on 11Mar2021 at 13:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and intermittent tachycardia. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), liothyronine (MANUFACTURER UNKNOWN) from an unknown date for hypothyroidism and multivitamin (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication. The patient was allergic to macrobid, cow dairy and isothiazolinone. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not tested for COVID-19. On 23Mar2021 at 11:00 (12 days after injection), the patient experienced injection site hot to the touch, injection site itchy, injection site painful and injection site red.  It seems to be a recurrence of the initial reaction, which went away after three days on an unspecified date. The clinical outcomes of the events injection site hot to the touch, injection site itchy, injection site painful and injection site red was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Panic attack, Throat tightness
Clinical narrative: throat closing; panic attack; This is a spontaneous report from a contactable consumer (patient). A 29-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-119 VACCINE, Solution for injection, lot number: EP6955) via unknown route of administration on 22Mar2021 12:00 PM in right arm at dose 1 single for COVID-19 immunization at Pharmacy or Drug Store. Medical history and Concomitant medications within 2 weeks of vaccination were not reported. Patient previously took rabeprazole (ACIPHEX) and had allergy. Patient experienced sensation of throat closing and panic attack on 22Mar2021 06:45 PM. Adverse events resulted in emergency room/department or urgent care. Treatment received for the adverse events included 50MG Benadryl and shot of dexamethasone. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Arm muscle ached; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN5318), via an unspecified route of administration on 23Mar2021 at 13:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not tested for COVID-19. On 23Mar2021 at 23:00, the patient experienced arm muscle ached. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No treatment was taken for the adverse event. The clinical outcome of arm muscle ache was resolved on unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: headache; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 71-years-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via an unspecified route of administration in the right arm on 19Mar2021 at 14:00 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. Medical history included Gastroesophageal reflux disease and cholesterol on an unspecified date. Allergies to medication included azithromycin (ZITHROMAX) on an unspecified date. Concomitant medications included Ranitidine (MANUFACTURER UNKNOWN) and Statins (MANUFACTURER UNKNOWN) for cholesterol on an unspecified. Patient previously received first dose BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: EN6203) in the right arm on 26Feb2021 (at the age of 71-years-old) as a single dose for Covid-19 immunisation. (The patient received other vaccines within 4 weeks prior to the COVID vaccine). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Patient experienced headache and fatigue on 20Mar2021. The patient did not receive treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache and fatigue was resolved.    No follow-up attempts possible. No further information expected
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Ear discomfort, Erythema, Lymphadenopathy, Pruritus
Clinical narrative: enlarged lymph node in neck; intermittent hot ears with erythema.  Left worse than right; mild itchiness to back of neck and upper back; intermittent hot ears; This is a spontaneous report from a contactable nurse, the patient. A 39-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6200), via an unspecified route of administration in the left arm on 10Mar2021 at 12:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Patient had no medical history. Concomitant medications were not reported. The patient did not had allergy to any medications, food, or other products. The patient previously received a first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201), via an unspecified route of administration in the left arm on 17Feb2021 at 12:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 10Mar2021, the patient experienced intermittent hot ears with erythema, left ear was worse than right, along with mild itchiness to back of neck and upper back. On 23Mar2021, thirteen days after injection she noted enlarged lymph node in neck and symptoms were still occurred. The patient had no other symptoms and never had this prior to the vaccine. It was unknown if the patient received any treatment for the events. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the intermittent hot ears with erythema, mild itchiness to back of neck and upper back and enlarged lymph node in neck was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Agitation, Blood pressure measurement, Chills, Diarrhoea, Dizziness
Clinical narrative: felt very agitated; diarrhea; chills; blood pressure and it was like 170over 90; racing heart; pulse rate of 110; dizzy; This is a spontaneous report from a contactable non-healthcare professional. A 56-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL3247), via an unspecified route of administration on the left arm on 17Mar2021 at 10:00 (at the age of 56-year-old), as a first single dose for COVID-19 immunisation. Medical history included bad back and knee. Concomitant medications included vit C (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN), zinc (MANUFACTURER UNKNOWN) all drugs started on an unknown date for unknown indications. The patient also reported that back was pulled out the week before and was in bed a few days and took a few unspecified muscle relaxers. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. On 18Mar2021 at 00:30, after the shot, the patient experienced that night when sleeping woke up witha racing heart and felt very agitated. The blood pressure and pulse rate were measured and recorded as 170 over 90 with a pulse rate of 110. The patient got up because felt dizzy. The patient walked around kitchen for an hour until it passed. It happened again two days later. On 21Mar2021, three days after the shot, the patient experienced diarrhea and chills. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events racing heart, felt very agitated, dizzy, diarrhea and chills were resolving at the time of the report.    No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased, Hypertension, Palpitations
Clinical narrative: felt very agitated; diarrhea; chills; blood pressure and it was like 170over 90; racing heart; pulse rate of 110; dizzy; This is a spontaneous report from a contactable non-healthcare professional. A 56-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL3247), via an unspecified route of administration on the left arm on 17Mar2021 at 10:00 (at the age of 56-year-old), as a first single dose for COVID-19 immunisation. Medical history included bad back and knee. Concomitant medications included vit C (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN), zinc (MANUFACTURER UNKNOWN) all drugs started on an unknown date for unknown indications. The patient also reported that back was pulled out the week before and was in bed a few days and took a few unspecified muscle relaxers. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. On 18Mar2021 at 00:30, after the shot, the patient experienced that night when sleeping woke up witha racing heart and felt very agitated. The blood pressure and pulse rate were measured and recorded as 170 over 90 with a pulse rate of 110. The patient got up because felt dizzy. The patient walked around kitchen for an hour until it passed. It happened again two days later. On 21Mar2021, three days after the shot, the patient experienced diarrhea and chills. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events racing heart, felt very agitated, dizzy, diarrhea and chills were resolving at the time of the report.    No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Pain, Pyrexia
Clinical narrative: fever; Body ache; Joint pain; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EN6205) via an unspecified route of administration in the left arm on 23Mar2021 at 11:15 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. The patients medical history included allergy to iodine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EJ6202) via an unspecified route of administration in the left arm on 02Mar2021 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Concomitant medications included tamoxifen (MANUFACTURER UNKNOWN), cetirizine hydrochloride (ZYRTEC) and vitamin D3 (MANUFACTURER UNKNOWN); all for an unknown indication and from an unknown date. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, patient had not been tested for COVID-19. On 24Mar2021 at 06:00, the patient had temperature of 101.2, body ache and joint pain. The patient did not receive any treatment for the events. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events having temperature, body ache and joint pain were unknown at the time of reporting.   No follow-up attempts are needed; No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Lymph node pain, Lymphadenopathy, Viral test
Clinical narrative: Swollen lymph nodes on right front/ side of neck; Very tender lymph nodes on right front/side of neck; Facial flushing on third day; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via unspecified route of administration in right arm on 19Mar2021 at 09:30 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included autoimmune thyroid. The patient had no allergies to medications, food, or other products, but she had issues breaking down histamine so environmental triggers could cause allergic-like reactions. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient had taken other medication (unspecified) in two weeks, prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19 and procedures included the Nasal Swab test in Dec2020, the result was negative. On 22Mar2021 at 09:30, the patient experienced facial flushing on third day and on 24Mar2021 the patient experienced swollen/ very tender lymph nodes on right front/side of neck on fifth day. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient had not received any treatment for the event. The clinical outcome of facial flushing, lymphadenopathy and lymph node tender were not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Fatigue, Headache, Myalgia
Clinical narrative: Fever; CHILLS; Cough; Fatigue; Muscle body ache; Headache; Nausea; Vomiiting; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via unspecified route of administration in the right arm on 23Mar2021 at 09:15 (at the age of 29 years) as a single dose for COVID-19 immunisation. The patient's medical history included pre-diabetic and high blood pressure at family medical history. Concomitant medication included ibuprofen (MANUFUTURER UNKNOWN). The patient did not had allergies to medications, food or other products. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had not tested positive for COVID-19 since having the vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3248) via unspecified route of administration in the right arm on 02Mar2021 at 09:30, as a single dose for COVID-19 immunisation. On 23Mar2021 at 22:00, the patient experienced fever, chills, cough, fatigue, muscle body ache, severe headache, nausea and vomiting. The adverse events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not received treatment for the adverse event. The clinical outcome of fever, chills, cough, fatigue, muscle body ache, severe headache, nausea and vomiting was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vomiting
Clinical narrative: Fever; CHILLS; Cough; Fatigue; Muscle body ache; Headache; Nausea; Vomiiting; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via unspecified route of administration in the right arm on 23Mar2021 at 09:15 (at the age of 29 years) as a single dose for COVID-19 immunisation. The patient's medical history included pre-diabetic and high blood pressure at family medical history. Concomitant medication included ibuprofen (MANUFUTURER UNKNOWN). The patient did not had allergies to medications, food or other products. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had not tested positive for COVID-19 since having the vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3248) via unspecified route of administration in the right arm on 02Mar2021 at 09:30, as a single dose for COVID-19 immunisation. On 23Mar2021 at 22:00, the patient experienced fever, chills, cough, fatigue, muscle body ache, severe headache, nausea and vomiting. The adverse events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not received treatment for the adverse event. The clinical outcome of fever, chills, cough, fatigue, muscle body ache, severe headache, nausea and vomiting was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore arm at the injection site; This is a spontaneous report received from a non-contactable consumer. A 33-year-old male patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the left arm on 22Mar2021, (at the age of 33-years-old) as a single dose, for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On 23Mar2021, the patient experienced sore arm at the injection site. The adverse event had not resulted in doctor or other healthcare professional office/clinic visit/ emergency visit/ department or urgent care. No therapeutic measures were taken as a result of vaccination site pain. The clinical outcome of the event vaccination site pain was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: After receiving my first shot ofthe vaccine the spots started goingaway. After my second shot one spotwas completely gone and the other isalmost gone; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH, Lot number: EN6203) via an unspecified route administration in left arm on 26Feb2021 (at the age of 64-year-old) at 11:15 hours, as a single dose for COVID-19 immunisation and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH, Lot number: EN6208) via an unspecified route administration in left arm on 17Mar2021 (at the age of 64-year-old)  at 13:15 as a single dose for COVID-19 immunisation. Medical history included Non-Hodgkin's Lymphoma. Patient did not have any allergies to medications, food, or other products. Concomitant medication included Tamsulosin (MANUFACTURER UNKNOWN), Losartan (MANUFACTURER UNKNOWN) and Pravastatin (MANUFACTURER UNKNOWN). Patient did not receive any other vaccine within 4 weeks prior to the covid-19. The patient was not diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19.  Patient reported that he had two spots of basil Cell skin cancer on right side of his face (Cheek). The basil cell was raised and scaly. After receiving the first shot of the vaccine the spots started going away (date unspecified). After the second shot (on 03Mar201) one spot was completely gone and the other was almost gone. He went to the dermatologist and they said they see no areas of concern (unexpected therapeutic benefit). No therapeutic measure was taken for the events. The clinical outcome of the events unexpected therapeutic benefit was unknown at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Insomnia, Pain, Pain in extremity
Clinical narrative: Almost a complete lack of sleep due to ache all over body; Almost a complete lack of sleep due to ache all over body; felt exhausted; arm where the shot was is sore and very tender; This is a spontaneous report from a non contactable consumer, the patient. A 52-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: Unknown) via an unspecified route in the left arm on 23Mar2021 at 15:00(at the age of 52 years old) as a single dose for COVID-19 immunisation. The patient had no medical history and  did not have any allergies to medications, food, or other products. The patient did not take any concomitant medication and did not receive any vaccination within four weeks prior to the COVID-19 vaccination.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. On 23Mar2021 at 22:00, the patient experienced complete lack of sleep due to ache all over body, felt exhausted, arm where the shot was is sore and very tender, though there are no swelling or shot location issues. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported event. The clinical outcome of the lack of sleep, ache all over body, exhausted, pain in arm and tenderness was recovering.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Restless legs syndrome
Clinical narrative: Increase in instances of RLS; This is a spontaneous report from a contactable consumer, the patient. A 66- years-old nonpregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206 ; Dose number: Unknown) administered on arm left on 11Mar2021  at 11:00,  as a single dose for COVID-19 immunisation (at the age of 66-year-old). Medical history included reported allergy to sulfa, welbutrin. Concomitant medications included ZOLOFT, ABILIFY within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination the patient was not tested for COVID-19. After vaccination, on an unknown date in Mar2021, the patient experienced an increase in instances of RLS. The patient had not received any treatment for the adverse event. The outcome of the event increase in instances of RLS was recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Lymphadenopathy, Pain
Clinical narrative: Swollen lymph nodes under left arm; Moderate pain; Some dizzy spells; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via an unspecified route in the left arm on 22Mar2021 at 12:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included glaucoma and high blood pressure. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any medicines within two weeks of COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021, the patient experienced swollen lymph nodes under left arm, moderate pain and some dizzy spells. Therapeutic measures were taken as a result of pain and included treatment with OTC medication. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event swollen lymph nodes under left arm, pain and dizziness was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Dry skin, Fatigue, Headache, Influenza like illness
Clinical narrative: Tiredness; Headache; bone and marrow pain; Nausea; Mild flu-like aches; Extremely dry skin; Flakey skin; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non- pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6200), via an unspecified route of administration in right arm on 08Mar2021 at 09:15 (at the age of 70-year-old), as a single dose for COVID-19 immunisation. Medical history included mild COPD, asthma and diet-exercise controlled diabetes. The patient was allergic to sulfa, cephalexin, neomycin, nickel, banana, soy & soy lecithin. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications received within two weeks of vaccination included umeclidinium bromide (INCRUSE), azilsartan kamedoxomil (EDARBI), vitamin D3 (MANUFACTURER UNKNOWN), duloxetine (MANUFACTURER UNKNOWN), ubiquinol (MANUFACTURER UNKNOWN) and ELLIPTA. All concomitant medications were taken from unspecified dates for unknown indication. On 09Mar2021 at 10:00, the patient experienced bone and marrow pain. On 10Mar2021, the patient experienced headache and tiredness. After a few days on an unknown date in Mar2021, the patient experienced nausea and mild flu-like aches. These last lasted on and off for a few days. She thought in that week her skin was extremely dry and flakey. It was reported that the patient had taken acetaminophen as a treatment measure for the reported event and took rest. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of bone and marrow pain, headache, tiredness, nausea, mild flu-like aches, dry and flakey skin was resolved on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.